Leucine aminopeptidase (LAP) detection kit (L-leucine-p-nitroaniline substrate method) - NMPA Registration 京械注准20232400386
Access comprehensive regulatory information for Leucine aminopeptidase (LAP) detection kit (L-leucine-p-nitroaniline substrate method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 京械注准20232400386 and owned by Beijing Leadman Biochemistry Co., Ltd.. The device was approved on June 20, 2023.
This page provides complete registration details including registrant information, province location (Beijing), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
This product is used for the in vitro quantitative determination of leucine aminotransferpeptidase (LAP) content in human serum.
本产品用于体外定量测定人血清中亮氨酸氨基转肽酶(LAP)的含量。

